MENU
DEC 14, 2021 7:00 AM PST

Understanding SARS-CoV-2 variants by Cryo-EM

Sponsored by: Thermo Fisher Scientific
Speaker
  • Professor of Pediatrics at Harvard Medical School and Boston Children's Hospital
    BIOGRAPHY

Abstract
Date:  December 14, 2021
Time: 7:00am (PST),  10:00am (EST)
 

Several fast-spreading variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have become the dominant circulating strains in the COVID-19 pandemic. Dr. Bing Chen and his colleagues from Harvard Medical School have determined cryo-EM structures of the full-length spike (S) trimers of the Alpha, Beta, Gamma, Kappa and Delta variants, and studied their function and antigenic properties.

Dr. Chen will discuss his latest research in this webinar:

· Mutations in the Alpha protein increase the accessibility of its receptor binding domain and also the binding affinity for receptor angiotensin-converting enzyme 2 (ACE2), possibly accounting for its increased transmissibility.

· The Beta variant has evolved to reshape antigenic surfaces of the major neutralizing sites on the S protein, making it resistant to potent neutralizing antibodies.

· Delta S can fuse membranes more efficiently at low levels of cellular receptor ACE2 and its pseudotyped viruses infect target cells substantially faster than the other five variants possibly accounting for its heightened transmissibility.

 

Dr. Chen and his colleagues have found out that each variant shows different rearrangement of the antigenic surface of the N-terminal domain of the S protein, but only cause local changes in the receptor-binding domain, making the receptor-binding domain (RBD) a better target for therapeutic antibodies. These findings provide structural details on how SARS-CoV-2 has evolved to enhance viral fitness and immune evasion.

 
 
 
Webinars will be available for unlimited on-demand viewing after live event.
 
 

Show Resources
You May Also Like
MAY 17, 2022 9:00 AM PDT
MAY 17, 2022 9:00 AM PDT
Date: May 17, 2022 Time: 9:00am (PDT), 12:00pm (EDT), 8:00pm (CEST) Gene therapeutics have great potential to treat many severe diseases in an unprecedented, targeted manner. The biopharmace...
APR 26, 2022 7:00 AM PDT
C.E. CREDITS
APR 26, 2022 7:00 AM PDT
Date: April 19, 2022 Time: 7:00am (PDT), 10:00am (EDT), 4:00pm (CEST) High-content (HC) phenotypic profiling approaches are a powerful tool to study the effect of biological, genetic, and ch...
DEC 09, 2021 11:00 AM PST
C.E. CREDITS
DEC 09, 2021 11:00 AM PST
Date: December 09, 2021 Time: 11:00am (PDT), 2:00pm (EDT) The burden of antimicrobial resistance (AMR) has been acknowledged worldwide by leading health institutes. Besides the need for new...
JAN 13, 2022 9:00 AM PST
C.E. CREDITS
JAN 13, 2022 9:00 AM PST
Date: January 13, 2022 Time: 09:00am (PST), 12:00pm (EST) Recently, the Infectious Disease Society of America released guidance on how to approach treatment of infections caused by multidrug...
JUN 16, 2022 10:00 AM PDT
JUN 16, 2022 10:00 AM PDT
Date: June 16, 2022 Time: 10:00am (PST), 1:00pm (EST), 7:00pm (CEST) Antimicrobial resistance (AMR) has emerged as a major health threat. The FED-AMR project part of the One Health European...
FEB 24, 2022 10:00 AM PST
C.E. CREDITS
FEB 24, 2022 10:00 AM PST
Date: February 24, 2021 Time: 10:00am (PST), 1:00pm (EST) One of the largest global public health crises is the rise of antimicrobial-resistant infections. Globally, over 700,000 people die...
Loading Comments...
Show Resources